Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis

被引：2

作者：

Farmakidis, C. ^{[1
]}

Leite, M. ^{[2
]}

Bresch, S. ^{[3
]}

Freimer, M. ^{[4
]}

Genge, A. ^{[5
]}

Hewamadduma, C. ^{[6
]}

Hussain, Y. ^{[7
]}

Maniaol, A. ^{[8
]}

Mantegazza, R. ^{[9
]}

Smilowski, M. ^{[10
]}

Utsugisawa, K. ^{[11
]}

Vu, T. ^{[12
]}

Duda, P. ^{[13
]}

Boroojerdi, B. ^{[14
]}

Vanderkelen, M. ^{[15
]}

de la Borderie, G. ^{[16
]}

Bloemers, J. ^{[16
]}

Howard, J., Jr. ^{[17
]}

机构：

[1] Univ Kansas, Neuromuscular Div, Dept Neurol, Med Ctr, Kansas City, MO USA

[2] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England

[3] Ctr Hosp Univ Nice, Nice, France

[4] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH USA

[5] Montreal Neurol Inst, Clin Res Unit, Montreal, PQ, Canada

[6] Univ Sheffield, Dept Neurosci, Sheffield, England

[7] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX USA

[8] Oslo Univ Hosp, Dept Neurol, Oslo, Norway

[9] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Neurol Carlo Besta, Milan, Italy

[10] Med Univ Silesia, Katowice, Poland

[11] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan

[12] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA

[13] UCB Pharma, Cambridge, MA USA

[14] UCB Pharma, Monheim, Germany

[15] UCB Pharma, Braine l Alleud, Belgium

[16] UCB Pharma, Brussels, Belgium

[17] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.440

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P273

引用

页码：S178 / S178

页数：1

共 50 条

[1] Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis
Genge, Angela
Leite, M. Isabel
Bresch, Saskia
Freimer, Miriam
Hewamadduma, Channa
Hussain, Yessar
Maniaol, Angelina
Mantegazza, Renato
Smilowski, Marek
Utsugisawa, Kimiaki
Vu, Tuan
Duda, Petra W.
Boroojerdi, Babak
Vanderkelen, Mark
De la Borderie, Guillemette
Bloemers, Jos
Howard, James F., Jr.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[2] Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis
Leite, M.
Bresch, S.
Freimer, M.
Genge, A.
Hewamadduma, C.
Hussain, Y.
Maniaol, A.
Mantegazza, R.
Smilowski, M.
Utsugisawa, K.
Vu, T.
Duda, P.
Boroojerdi, B.
Vanderkelen, M.
De la Borderie, G.
Bloemers, J.
Howard, J., Jr.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 462 - 462
[3] LONG-TERM SAFETY AND EFFICACY OF ZILUCOPLAN IN GENERALIZED MYASTHENIA GRAVIS: 120-WEEK INTERIM ANALYSIS OF RAISE-XT
Howard, James F., Jr.
Freimer, Miriam
Genge, Angela
Hewamadduma, Channa
Hussain, Yessar
Maniaol, Angelina
Mantegazza, Renato
Utsugisawa, Kimiaki
Vu, Tuan
Weiss, Michael D.
Boroojerdi, Babak
Duda, Petra W.
Grimson, Fiona
Vanderkelen, Mark
Leite, M. Isabel
MUSCLE & NERVE, 2024, 70 (03) : 548 - 548
[4] Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
Howard Jr, James F.
Bresch, Saskia
Farmakidis, Constantine
Freimer, Miriam
Genge, Angela
Hewamadduma, Channa
Hinton, John
Hussain, Yessar
Juntas-Morales, Raul
Kaminski, Henry J.
Maniaol, Angelina
Mantegazza, Renato
Masuda, Masayuki
Nowak, Richard J.
Sivakumar, Kumaraswamy
Smilowski, Marek
Utsugisawa, Kimiaki
Vu, Tuan
Weiss, Michael D.
Zajda, Malgorzata
Bloemers, Jos
Boroojerdi, Babak
Brock, Melissa
de la Borderie, Guillemette
Duda, Petra W.
Vanderkelen, Mark
Leite, M. Isabel
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
[5] RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis
Freimer, Miriam
Leite, M. Isabel
Genge, Angela
Hussain, Yessar
Kaminski, Henry J.
Mantegazza, Renato
Utsugisawa, Kimiaki
Vu, Tuan
Duda, Petra W.
Boroojerdi, Babak
Vanderkelen, Mark
Lowcock, Romana
Howard, James F., Jr.
NEUROLOGY, 2023, 100 (17)
[6] Corticosteroid dose tapering in patients with generalised myasthenia gravis on zilucoplan: an interim analysis of RAISE-XT
Boroojerdi, B.
Freimer, M.
Genge, A.
Hewamadduma, C.
Leite, M.
Lejdstrom, R. Beau
Grimson, F.
Savic, N.
Howard, J., Jr.
NEUROMUSCULAR DISORDERS, 2024, 43
[7] SAFETY AND TOLERABILITY OF ZILUCOPLAN IN RAISE-XT: A MULTICENTER, OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH MYASTHENIA GRAVIS
Genge, Angela
Hussain, Yessar
Kaminski, Henry J.
Leite, M. Isabel
Mantegazza, Renato
Utsugisawa, Kimiaki
Vu, Tuan
Brock, Melissa
Boroojerdi, Babak
Vanderkelen, Mark
de la Borderie, Guillemette
Duda, Petra W.
Howard, James F., Jr.
MUSCLE & NERVE, 2022, 66 : S131 - S131
[8] COMPLIANCE TO DAILY SELF-ADMINISTERED SUBCUTANEOUS ZILUCOPLAN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A POST HOC ANALYSIS OF THE RAISE-XT STUDY
Ruzhansky, Katherine
Freimer, Miriam
Leite, M. Isabel
Maniaol, Angelina
Mantegazza, Renato
Utsugisawa, Kimiaki
Vu, Tuan
Weiss, Michael D.
Boroojerdi, Babak
Grimson, Fiona
Savic, Natasa
Howard, James F., Jr.
MUSCLE & NERVE, 2024, 70 (03) : 590 - 591
[9] EFFICACY AND SAFETY OF ZILUCOPLAN IN MYASTHENIA GRAVIS: RESPONDER ANALYSIS FROM THE RANDOMIZED PHASE 3 RAISE TRIAL
Vu, Tuan
Genge, Angela
Hussain, Yessar
Kaminski, Henry
Leite, Maria Isabel
Mantegazza, Renato
Utsugisawa, Kimiaki
Brock, Melissa
Boroojerdi, Babak
Vanderkelen, Mark
de la Borderie, Guillemette
Duda, Petra
Howard, James
MUSCLE & NERVE, 2022, 66 : S108 - S109
[10] Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
Kim, Yool-hee
Shin, Ha Young
Kim, Seung Min
YONSEI MEDICAL JOURNAL, 2019, 60 (07) : 633 - 639

← 1 2 3 4 5 →